News

Longevity. Technology
longevity. technology > news > an-eu-moonshot-to-solve-aging

An EU moonshot to solve aging

14+ hour, 41+ min ago  (449+ words) For years, the longevity field has made a familiar complaint: aging is the single largest risk factor for chronic disease, yet almost no major funder treats it as a target in its own right. That's quietly changing " and most of…...

Symbols: nyse:lly,nyse:nvo,nasdaq:vktx,nasdaq:lgvn
Google News
finance. yahoo. com > healthcare > articles > matricelf-advances-toward-first-human-110000576. html

Matricelf Advances Toward First in Human Trial Following Successful GLP Safety Study Completion

1+ week, 19+ hour ago  (217+ words) TEL AVIV, Israel, June 17, 2026 /PRNewswire/ --Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue implants for spinal cord injury, today announced the successful completion of its comprehensive GLP safety study for its engineered neural tissue implant, achieving…...

Symbols: nasdaq:lexx
Drug Target Review
drugtargetreview. com > new-framework-standardises-glioma-organoid-research-for-translational-studies > 2135731. article

New framework standardises glioma organoid research for translational studies

1+ week, 21+ hour ago  (334+ words) Researchers from the Terasaki Institute for Biomedical Innovation and leading experts in glioma biology, neuro-oncology and stem cell biology have published a major review outlining a new framework for glioma organoid research. The paper, published in the journal Neuro-Oncology, examines…...

Symbols: nasdaq:cnsp
Bio Space
biospace. com > press-releases > aviadobio-expands-vmix-precision-gene-silencing-platform-exclusive-license-agreement-with-kings-college-london-beyond-neurological-diseases-to-all-human-therapeutic-areas

Aviado Bio Expands v Mi X" Precision Gene Silencing Platform Exclusive License Agreement with King's College London Beyond Neurological Diseases to All Human Therapeutic Areas

1+ week, 1+ day ago  (231+ words) v Mi X" is a vectorized RNA interference (RNAi) platform combining knockdown, cell-specific expression with the flexibility to target multiple genes Update follows recent positive AVB-406 preclinical data presented at ASGCT, supporting the broad therapeutic potential of the v Mi…...

Symbols: btc-usd
Medical Buyer
medicalbuyer. co. in > in-vitro-toxicology-testing-market-to-exceed-usd-20-97b

In vitro toxicology testing market to exceed USD 20. 97 B

1+ week, 1+ day ago  (178+ words) Medical Buyer The in vitro toxicology testing market is projected to grow from about USD 12. 69 billion in 2026 to USD 20. 97 billion by 2031, at a CAGR of 10. 6%, according to Marketsand Markets. The growth of the in vitro toxicology testing market is driven…...

Symbols: btc-usd
Google News
nippon. com > en > news > yjj2026061600117

Researchers Identify 25 New Biomarkers for Cyanide Poisoning

1+ week, 1+ day ago  (151+ words) Tokyo, June 16 (Jiji Press)--Researchers in Japan have identified 25 new biomarkers for cyanide poisoning, a finding that could sharpen criminal investigations and improve forensic determinations of cause of death. The study, conducted by a team of researchers at institutions including…...

Symbols: lloy.l,shel.l,0mc5.il,0rcr.il,0dp0.il,0fmo.il
Telangana Today
telanganatoday. com > pesticide-related-diseases-going-undiagnosed-in-rural-india-research

Pesticide-related diseases going undiagnosed in rural India: Research

1+ week, 2+ day ago  (369+ words) A new study warns that India's healthcare system is failing to identify pesticide-related illnesses in farming communities. Gaps in medical education, limited toxicology training, and inadequate patient questioning mean chronic diseases linked to pesticide exposure often go undiagnosed and unreported....

Eurek Alert!
eurekalert. org > multimedia > 1136070

Terasaki Institute Researchers and Key Pioneers Publish Comprehensive Review on Glioma Organoid Models, Proposing New Classification Framework for Brain Cancer Research

1+ week, 2+ day ago  (111+ words) Eurek Alert! Pictured from top left to right: Dr. Zhaohui Wang, Terasaki Institute; Dr. Hongjun Song, University of Pennsylvania; Dr. Christopher Hubert, Case Western Reserve University. Bottom left to right: Dr. Albert Lai, UCLA; Dr. Tyler Miller, Case Western Reserve…...

Symbols: nasdaq:cnsp
Contract Pharma
contractpharma. com > live_from_shows > lonza-antharis-therapeutics-partner-to-develop-novel-dual-payload-adcs

Lonza, Antharis Therapeutics Partner to Develop Novel Dual-Payload ADCs

1+ week, 2+ day ago  (290+ words) Contract Pharma Lonza, Antharis Therapeutics Partner to Develop Novel Dual-Payload ADCs Antharis" proprietary antibody engineering and target biology expertise will be integrated with Lonza"s clinically validated, site-specific ADC technologies. Lonza and Antharis Therapeutics Inc. , a biopharmaceutical company developing next-generation…...

Symbols: btc-usd
BIOENGINEER. ORG
bioengineer. org > enhancing-biologic-delivery-formulations-for-oesophagus

Enhancing Biologic Delivery Formulations for Oesophagus

1+ week, 2+ day ago  (712+ words) Bioengineer. org...

Symbols: btc-usd